DULCOLAX SUPPOSITORY

Land: Canada

Språk: engelsk

Kilde: Health Canada

Aktiv ingrediens:

BISACODYL

Tilgjengelig fra:

SANOFI CONSUMER HEALTH INC

ATC-kode:

A06AB02

INN (International Name):

BISACODYL

Dosering :

10MG

Legemiddelform:

SUPPOSITORY

Sammensetning:

BISACODYL 10MG

Administreringsrute:

RECTAL

Enheter i pakken:

3/6/100

Resept typen:

OTC

Terapeutisk område:

CATHARTICS AND LAXATIVES

Produkt oppsummering:

Active ingredient group (AIG) number: 0101506002; AHFS:

Autorisasjon status:

APPROVED

Autorisasjon dato:

2019-12-09

Preparatomtale

_ _
_Dulcolax Prescribing Information _
_Page 1 of 12 _
PRESCRIBING INFORMATION
DULCOLAX
®
Bisacodyl
Tablets 5 mg
Suppositories 10 mg
Manufacturer’s Standard
Stimulant Laxative
sanofi-aventis Canada Inc.
2905 Louis-R.-Renaud Place
Laval, Quebec H7V 0A3
Date of Revision:
November 7, 2017
Submission Control No:210082
CCDS: 0074-07
_ _
_Dulcolax Prescribing Information _
_Page 2 of 12 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
.....................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
...............................................................................4
ADVERSE REACTIONS
....................................................................................................5
DOSAGE AND ADMINISTRATION
................................................................................6
OVERDOSAGE
..................................................................................................................7
STORAGE AND STABILITY
............................................................................................7
DOSAGE FORMS, COMPOSITION AND PACKAGING
...............................................8
PART III: CONSUMER
INFORMATION................................................................................9
PART III: CONSUMER
INFORMATION..............................................................................11
_ _
_Dulcolax Prescribing Information _
_Page 3 of 12 _
DULCOLAX
®
Bisacodyl
PART I: HEALTH PROFESSIONAL INFORMATION
SUMMARY PRODUCT INFORMATION
ROUTE OF
ADMINISTRATION
DOSAGE FORM /
STRENGTH
CLINICALLY RELEVANT NONMEDICINAL INGREDIENTS
Oral
tablet 5 mg
acacia, white wax, carnauba wax, corn starch
(dried/soluble), methacry